Sign in Pull a receipt

TVTX

Travere Therapeutics, Inc.

Biotechnology · Biotechnology

$224.78 sample

-1.38 (-0.61%) 1D

Market cap

$687.5B

Price as of

2026-10-29

Latest filing

8-K · 2026-09-25

Alerts

8

Price$224.78 -0.89% 3M daily closessample

250.91221.63

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 26INSInsider sell: Chief Executive Officer
Oct 19INSInsider sell: Chief Executive Officer
Oct 13INSInsider sell: Director
Oct 08INSInsider buy: Chief Executive Officer
Oct 02INSInsider sell: General Counsel
Sep 25SECDEF 14A filed
Sep 17INSInsider sell: 10% owner
Sep 14SECForm 144 filed

Sign up to see the real TVTX record →

Company facts

SEC EDGAR registration

Name: Travere Therapeutics, Inc.
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: +21sample, -100 to +100
Reporting currency: USD

Who is positioning in TVTX

sample

Insiders: 21 insider transactions over 90 days, net selling, $163.3M
Congress: 5 members traded over 90 days
Institutions · 13F: 12 funds hold $13.6B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$25.1B +14.0% y/y

Q4 2024Q3 2026

Inventory$15.6B +13.8% y/y

Q4 2024Q3 2026

Accounts receivable$11.6B +9.4% y/y

Q4 2024Q3 2026

Total debt$30.7B +16.9% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $502.0B +2.5% 3M
Sample peer B: $139.6B +9.8% 3M
Sample peer C: $426.9B +4.7% 3M
Sample peer D: $334.2B +4.2% 3M
Sample peer E: $298.2B -9.7% 3M